Chijioke C. Nze MD, MPHHematology/Oncology Fellow, MD Anderson Cancer Center, Houston, Texas
Chijioke Nze, MD, MPH is a Hematology & Oncology fellow at The University of Texas MD Anderson Cancer Center. He received his medical degree at Harvard medical school and a Master in Public Health (MPH) at Harvard T.H. Chan School of Public Health with a focus on health policy.
His clinical interests are currently ranging within benign hematology, malignant hematology and oncology. He is broadly interested in healthcare delivery system design, value-based healthcare research and the health policy contexts that shape care delivery. He has been a longtime advocate for equity in health care delivery and what elements that lead to differential access and outcomes in care for vulnerable populations. He has published opinion pieces on topics such as the role of physicians in advocacy after police brutality and how we ensure equity in care for patients with limited English proficiency. He aims to combine excellence in the delivery of clinical oncologic care to cancer patients with investigating how we can optimally structure our healthcare system to ensure equitable cancer care for all. His mission is in keeping with that of MD Andersons which is to make cancer history and eliminate cancer here and everywhere.
- Green AR and Nze. Language-Based Inequity in Health Care: Who Is the “Poor Historian”? AMA Journal of Ethics. March 2017, Volume 19, Number 3: 263-271
- Nze C., Avakame E., Ayankola J. and Nwanaji-Enwerem. Police brutality is our lane too, doctos say. STAT. June 5 2020
Peer reviewed publications
- Green AR., Rosu C., Kenison T., and Nze C. "Assessing the hidden curriculum for the care of patients with limited english proficiency: An instrument development." Education for Health 31, no. 1 (2018): 17.
- Nze C., Fortin B., Freedman R., Mandell E., Puligandla M., Neuberg D., and Achebe, M. Sudden death in Sickle Cell Disease: Current experience.
Recent Contributions to PracticeUpdate:
- Analyzing Racial and Ethnic Disparities in Multiple Myeloma FDA Drug Approval Trials
- Association of Race/Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Enrolled in VA and Medicare
- Socioeconomic Status and Suboptimal Iron Deficiency Screening in Pregnancy
- Eliminating Race-Based Reference Ranges in Haematology